SeqOnce Biosciences Adds RT-qPCR Measles Panel
SeqOnce has launched Measles Panel A, a new RT-qPCR assay designed to detect all known measles genotypes—including the D8 genotype.
SeqOnce has launched Measles Panel A, a new RT-qPCR assay designed to detect all known measles genotypes—including the D8 genotype.
The FDA granted 510(k) clearance for Roche STI multiplex panels, enabling rapid diagnosis of chlamydia, gonorrhea, and Mycoplasma genitalium.
Roche introduced the cobas Respiratory flex test which uses TAGS technology to identify up to 15 pathogens in a single PCR test.
Roche launched new analytical units, cobas c 703 and cobas ISE neo, for the cobas pro integrated solutions.
Read MoreRoche’s VENTANA DP 200 whole slide imaging system has received FDA clearance for diagnosing patients through digital pathology.
Read MoreRoche’s cobas liat COVID, Influenza A/B & RSV test, is a rapid RT-PCR assay that detects multiple respiratory viruses from a single sample.
Read MoreALZpath and Roche will develop a blood test for Alzheimer’s diagnosis using the pTau217 antibody on the Roche Elecsys platform.
Read MoreRoche and Hitachi High-Tech have extended their partnership for at least 10 more years and will continue to focus on advancing lab tech.
Read MoreRoche announced that its Tina-quant lipoprotein Lp(a) RxDx assay received Breakthrough Device Designation from the FDA.
Read MoreThe CLP March/April 2024 Tech Guide in Clinical Lab Products (CLP) showcases a diverse array of products from seven laboratory providers.
Read Moreche received FDA approval for its HPV self-collection solution, allowing individuals to collect their own samples.
Read MoreRoche’s Elecsys pTau217 assay could help rapidly broaden access to a more timely and accurate diagnosis of Alzheimer’s disease. Â
Read MoreRoche announced U.S. FDA approval of the cobas Malaria test for use on the cobas 6800/8800 Systems to aid healthcare professionals.
Read MoreSherlock Bio is making its proprietary AI platform freely available to anyone interested in developing diagnostics assays.
Read MoreRoche’s new suite of cloud-based solutions provides actionable insights to optimize operational outcomes in labs and point-of-care settings.
Read MorePathAI will exclusively work with Roche Tissue Diagnostics to develop AI-enabled digital pathology algorithms for companion diagnostics.
Read MoreThe January/February 2024 Tech Guide that appears in CLP features a wide-range of products from top laboratory providers.
Read MoreThe new qPCR system raises the bar for performance and usability while bridging the gap between research and in vitro diagnostics.
Read More